Citation Impact
Citing Papers
Feasibility of the Use of Phosphodiesterase Type 5 Inhibitors in a Pharmacologic Prevention Program for Recurrent Priapism
2006
Curcumin, the golden nutraceutical: multitargeting for multiple chronic diseases
2016 Standout
A RASSF1A-HIF1α loop drives Warburg effect in cancer and pulmonary hypertension
2019 StandoutNobel
Haemodynamic definitions and updated clinical classification of pulmonary hypertension
2018 Standout
Long-Term Outcome and Evaluation of Organ Function in Pediatric Patients Undergoing Haploidentical and Matched Related Hematopoietic Cell Transplantation for Sickle Cell Disease
2013
Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study
2013
Management of Sickle Cell Disease
2014
Ischemia and reperfusion—from mechanism to translation
2011 Standout
Review: Hemodynamic Characteristics and Outcomes of Sickle Cell Disease Associated Pulmonary Hypertension
2016
Pulmonary hypertension in sickle cell disease
2015
Therapeutic potential of resveratrol: the in vivo evidence
2006 Standout
The Clinical Sequelae of Intravascular Hemolysis and Extracellular Plasma Hemoglobin
2005 Standout
Erythroid adhesion molecules in sickle cell disease: Effect of hydroxyurea
2008
Arginine therapy of transgenic-knockout sickle mice improves microvascular function by reducing non-nitric oxide vasodilators, hemolysis, and oxidative stress
2008
Mortality in Adults With Sickle Cell Disease and Pulmonary Hypertension
2012
Acute chest syndrome of sickle cell disease: new light on an old problem
2001
CASK and Protein 4.1 Support F-actin Nucleation on Neurexins
2001 StandoutNobel
Plasma hydroxyurea determined by gas chromatography–mass spectrometry
2008
Clinical methods for the evaluation of endothelial function – a focus on resistance arteries
2006
Sickle cell disease
2017
Therapeutic Roles of Curcumin: Lessons Learned from Clinical Trials
2012 Standout
Cardiovascular complications and risk of death in sickle-cell disease
2016
Evidence review of hydroxyurea for the prevention of sickle cell complications in low-income countries
2013
Management of Patients with Sickle Cell Disease Using Transfusion Therapy
2016
Pediatric Pulmonary Hypertension
2013
Applications of genome editing technology in the targeted therapy of human diseases: mechanisms, advances and prospects
2020 Standout
Cerebrovascular disease associated with sickle cell pulmonary hypertension
2006
Definitions and Diagnosis of Pulmonary Hypertension
2013 Standout
A global view of pulmonary hypertension
2016 Standout
Red cell pyruvate kinase deficiency: molecular and clinical aspects
2005
Updated Clinical Classification of Pulmonary Hypertension
2009 Standout
Infection in sickle cell disease: A review
2009
Systemic sclerosis
2017 Standout
Effect of fetal hemoglobin on microvascular regulation in sickle transgenic-knockout mice
2004
Molecular analysis of insertion/deletion mutations in protein 4.1 in elliptocytosis. II. Determination of molecular genetic origins of rearrangements.
1990 StandoutNobel
Preliminary Assessment of Inhaled Nitric Oxide for Acute Vaso-occlusive Crisis in Pediatric Patients With Sickle Cell Disease
2003
Ultrathin conformal devices for precise and continuous thermal characterization of human skin
2013 Standout
Lu/BCAM Adhesion Glycoprotein Is a Receptor for Escherichia coli Cytotoxic Necrotizing Factor 1 (CNF1)
2014
Heart Failure with Preserved and Reduced Ejection Fraction in Hemodialysis Patients: Prevalence, Disease Prediction and Prognosis
2017 Standout
Evidence for a metabolic shift of arginine metabolism in sickle cell disease
2004
Pulmonary Hypertension and Cor Pulmonale during Severe Acute Chest Syndrome in Sickle Cell Disease
2008
Clinical management of adult sickle-cell disease
2012
Hippo Pathway in Organ Size Control, Tissue Homeostasis, and Cancer
2015 Standout
Early detection of pulmonary arterial hypertension
2014
Prevention of hepatotoxicity due to anti tuberculosis treatment: A novel integrative approach
2008
Causes of death in sickle cell disease: an autopsy study
2003
Management of sickle cell priapism with etilefrine
2001
Biological roles of glycans
2016 Standout
Sickle cell anemia is associated with reduced nitric oxide bioactivity in peripheral conduit and resistance vessels
2003
Cardiomyopathy With Restrictive Physiology in Sickle Cell Disease
2016
The Medical Research Council chronic dyspnea score predicts the survival of patients with idiopathic pulmonary fibrosis
2008
cGMP-Dependent Protein Kinases and cGMP Phosphodiesterases in Nitric Oxide and cGMP Action
2010 Standout
Outcome of Sickle Cell Anemia
2005
Diastolic Dysfunction Is an Independent Risk Factor for Death in Patients With Sickle Cell Disease
2007
Inorganic nitrite therapy: historical perspective and future directions
2011
Red cell pyruvate kinase deficiency: from genetics to clinical manifestations
2000
Reconstructing sickle cell disease: A data‐based analysis of the “hyperhemolysis paradigm” for pulmonary hypertension from the perspective of evidence‐based medicine
2010
A cell stress signaling model of fetal hemoglobin induction: what doesn't kill red blood cells may make them stronger
2008
Updated Clinical Classification of Pulmonary Hypertension
2013 Standout
The clinical impact of glycobiology: targeting selectins, Siglecs and mammalian glycans
2021 StandoutNobel
Plant Polyphenols: Chemical Properties, Biological Activities, and Synthesis
2011 Standout
Sickle cell disease: no longer a single gene disorder
2001
Sickle-cell disease
2010 Standout
Mitochondrial Membrane Permeabilization in Cell Death
2007 Standout
Analysis of anticancer drugs: A review
2011 Standout
Management of Chronic Kidney Disease Patients in the Intensive Care Unit: Mixing Acute and Chronic Illness
2017 Standout
Elevated Pulse Pressure is Associated with Hemolysis, Proteinuria and Chronic Kidney Disease in Sickle Cell Disease
2014
The Registry of the International Society for Heart and Lung Transplantation: Thirty-fourth Adult Lung And Heart-Lung Transplantation Report—2017; Focus Theme: Allograft ischemic time
2017 Standout
α‐Actinin is a potent regulator of G protein‐coupled receptor kinase activity and substrate specificity in vitro
2000 StandoutNobel
Infrared imaging of nitric oxide-mediated blood flow in human sickle cell disease
2012
Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease
2002
Urinary tract infections: epidemiology, mechanisms of infection and treatment options
2015 Standout
Pulmonary Complications of Sickle Cell Disease
2008
Effect of resveratrol on cell cycle proteins in murine transplantable liver cancer
2003
Prevalence, Predictors, and Outcomes of Pulmonary Hypertension in CKD
2015
Circumstances of death in adult sickle cell disease patients
2006
Mechanisms and pathophysiological significance of eryptosis, the suicidal erythrocyte death
2015 Standout
The spectrin-actin junction of erythrocyte membrane skeletons
1989
Prevalence of pulmonary hypertension in hereditary spherocytosis
2011
Arginine metabolism and nutrition in growth, health and disease
2008 Standout
Hemodynamic Predictors of Mortality in Adults with Sickle Cell Disease
2013
Clinical Course and Prediction of Survival in Idiopathic Pulmonary Fibrosis
2010 Standout
Pulmonary Complications of Sickle Cell Disease
2012
2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association
2021 Standout
Evidence that red blood cell protein p55 may participate in the skeleton-membrane linkage that involves protein 4.1 and glycophorin C
1993
Extracellular DNA traps promote thrombosis
2010 Standout
Biochemical surrogate markers of hemolysis do not correlate with directly measured erythrocyte survival in sickle cell anemia
2016
The spleen and sickle cell disease: the sick(led) spleen
2014
Mechanisms of Cell Protection by Heme Oxygenase-1
2010 Standout
Expression Pattern of HIF-1α and VEGF Supports Circumferential Application of Scatter Laser for Proliferative Sickle Retinopathy
2016 StandoutNobel
Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies.
2004 Standout
Cellular normoxic biophysical markers of hydroxyurea treatment in sickle cell disease
2016
Identification and transcriptome analysis of erythroblastic island macrophages
2019 StandoutNobel
The Spectrin-Based Membrane Skeleton and Micron-Scale Organization of the Plasma Membrane
1993
Nitric oxide therapy in sickle cell disease
2001
Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease
2002
Isolation of the cDNA for erythrocyte integral membrane protein of 28 kilodaltons: member of an ancient channel family.
1991 StandoutNobel
Pulmonary hypertension and nitric oxide depletion in sickle cell disease
2010
Prevalence and Risk Factors for Pulmonary Arterial Hypertension in a Large Group of β-Thalassemia Patients Using Right Heart Catheterization
2013
Hemolysis-associated priapism in sickle cell disease
2005
Divergent Nitric Oxide Bioavailability in Men and Women With Sickle Cell Disease
2003
Resveratrol blocks interleukin-1β–induced activation of the nuclear transcription factor NF-κB, inhibits proliferation, causes S-phase arrest, and induces apoptosis of acute myeloid leukemia cells
2003
JAK2V617F activates Lu/BCAM-mediated red cell adhesion in polycythemia vera through an EpoR-independent Rap1/Akt pathway
2012
Heparin inhibits the flow adhesion of sickle red blood cells to P-selectin
2002
Role of erythrocyte phosphatidylserine in sickle red cell–endothelial adhesion
2002
Delayed hemolytic transfusion reaction in children with sickle cell disease
2011
Reactive species in non-equilibrium atmospheric-pressure plasmas: Generation, transport, and biological effects
2016 Standout
Human erythrocyte glycophorin C
1989
Estimated pulmonary artery systolic pressure and sickle cell disease: a meta‐analysis and systematic review
2015
Six Months of Hydroxyurea Reduces Albuminuria in Patients with Sickle Cell Disease
2015
High prevalence of red blood cell alloimmunization in sickle cell disease despite transfusion from Rh-matched minority donors
2013
Effect of fetal hemoglobin on microvascular regulation in sickle transgenic-knockout mice
2004
Pathophysiology and treatment of pulmonary hypertension in sickle cell disease
2016
Transfusion therapy for sickle cell disease: a balancing act
2013
Sevuparin binds to multiple adhesive ligands and reduces sickle red blood cell‐induced vaso‐occlusion
2016
Factors associated with survival in a contemporary adult sickle cell disease cohort
2014
How I manage cerebral vasculopathy in children with sickle cell disease
2015
Molecular targets of dietary agents for prevention and therapy of cancer
2006 Standout
Red blood cell alloimmunization in sickle cell disease: pathophysiology, risk factors, and transfusion management
2012
Erythrocyte Mr 28,000 transmembrane protein exists as a multisubunit oligomer similar to channel proteins.
1991 StandoutNobel
The return of metabolism: biochemistry and physiology of the pentose phosphate pathway
2014 Standout
Quantitative phase imaging in biomedicine
2018 Standout
Sodium-Potassium-Chloride Cotransport
2000 Standout
Endothelial Function and Dysfunction
2007 Standout
Works of Dora Bachir being referenced
Decreased sickle red blood cell adhesion to laminin by hydroxyurea is associated with inhibition of Lu/BCAM protein phosphorylation
2010
A Hemodynamic Study of Pulmonary Hypertension in Sickle Cell Disease
2011
Plasma and Urine Hydroxyurea Levels Might be Useful in the Management of Adult Sickle Cell Disease
2007
Clinical Follow-Up of Hydroxyurea-Treated Adults with Sickle Cell Disease
2010
Population pharmacokinetics and pharmacodynamics of hydroxyurea in sickle cell anemia patients, a basis for optimizing the dosing regimen
2011
Acute Chest Syndrome in Adults With Sickle Cell Disease
2000
Early intermittent noninvasive ventilation for acute chest syndrome in adults with sickle cell disease: a pilot study
2010
Resveratrol, a natural dietary phytoalexin, possesses similar properties to hydroxyurea towards erythroid differentiation
2001
Preventive treatment of priapism in sickle cell disease with oral and self-administered intracavernous injection of etilefrine
1996
Clinical and Laboratory Factors Associated With the Severity of Proliferative Sickle Cell Retinopathy in Patients With Sickle Cell Hemoglobin C (SC) and Homozygous Sickle Cell (SS) Disease
2011
Bloodstream Infection in Adults With Sickle Cell Disease
2006
Factors Associated With Dyspnea in Adult Patients With Sickle Cell Disease
2005
A new sickle cell disease phenotype associating Hb S trait, severe pyruvate kinase deficiency (PK Conakry), and an α2 globin gene variant (Hb Conakry)
1998
Patterns of mortality in sickle cell disease in adults in France and England
2002
Delayed hemolytic transfusion reaction in sickle cell disease patients: evidence of an emerging syndrome with suicidal red blood cell death
2009
Induced Sputum versus Bronchoalveolar Lavage during Acute Chest Syndrome in Sickle Cell Disease
2003
Endothelial dysfunction in patients with sickle cell disease is related to selective impairment of shear stress–mediated vasodilation
2001
Gerbich reactivity in 4.1(—) hereditary elliptocytosis and protein 4.1 level in blood group Gerbich deficiency
1987
The nonexpression of CD36 on reticulocytes and mature red blood cells does not modify the clinical course of patients with sickle cell anemia
2001
Prospective Multicentric Survey On Pulmonary Hypertension (PH) in Adults with Sickle Cell Disease.
2009
Rare RHCE phenotypes in black individuals of Afro-Caribbean origin: identification and transfusion safety
2002
A randomized, controlled clinical trial of ketoprofen for sickle-cell disease vaso-occlusive crises in adults
2009